P atients with peripheral arterial disease (PAD) develop intermittent claudication with walking exercise because extremity blood flow is limited and inadequate to meet the metabolic demand of the muscle.1 This results in an objective impairment in exercise performance, such that the peak oxygen consumption during treadmill testing is 50% lower than values in age-matched controls. 2 The etiology of the exercise impairment in patients with PAD is multifac-torial. Although muscle ischemia is a major contributor, the hemodynamic severity of the disease (assessed by measurements of peripheral blood flow or ankle pressure) is poorly correlated with exercise performance.3 '4 Patients with severe ischemic disease develop structural changes in skeletal muscle consisting of denervation, fiber atrophy, and a selective loss of type II fibers relative to type I fibers that may contribute to the muscle dysfunction.5-7 Ambulatory patients with mild PAD also have muscle weakness and reduced muscle endurance,8 but it is not established whether denervation and fiber atrophy also contribute to their impairment in muscle function.
In patients with PAD, an increase in skeletal muscle oxidative enzyme activity may be an adaptive response to the reduced skeletal muscle blood flow.9-1' However, other investigators have observed a decrease in oxidative enzyme activity in PAD, particularly in more severe forms of the disease.12"13 Thus, changes in skeletal muscle enzyme activities in patients with PAD may be heterogeneous, and the functional significance of these changes is not well established.
To further define the structural and metabolic changes that occur in skeletal muscle of ambulatory 
Subjects
Twenty-six male patients with PAD were studied, of which 10 had intermittent claudication in only one leg (unilateral patients), and 16 had claudication in both legs. Unilateral PAD was confirmed by an abnormal ankle-to-brachial systolic blood pressure indexes (ABIs) in the symptomatic leg (see below). In the unilateral patients, four had aortoiliac disease, whereas all 10 had femoropopliteal disease as identified by segmental limb pressures and pulse volume recordings using established criteria.14 Six age-and activitymatched control subjects were also enrolled ( 
Treadmill Testing
In patients with PAD, a graded treadmill protocol was performed to maximally tolerated claudication pain using previously described and validated methods.4 Controls exercised to exhaustion using the same protocol. Rates of oxygen consumption (Vo2) and carbon dioxide production (Vco2) were measured at rest and during treadmill exercise with an Ametek metabolic system (Ametek Thermox, Pittsburgh, Pa.). Arm blood pressure (by auscultation) and heart rate (by 12-lead ECG) were obtained every minute during exercise. Cardiac To estimate the maximal calf muscle cross-sectional area, calf circumference (in centimeters) was measured at the largest part of the muscle and converted to cross-sectional area by the following formula: circumference2/41r (assuming the calf to be nearly circular). In addition, a subset of six unilateral PAD patients and three controls underwent computed tomography (CT) scanning (model CT-900S series, Toshiba Corporation, Nasu, Japan) of each calf. A single 1-cm scan was obtained simultaneously through both calves at the level of the biopsy sites with the legs parallel. The perimeter of the calf musculature was manually traced (excluding the tibia, fibula, and subcutaneous tissue), and the cross-sectional area (in centimeters squared) of the muscle was calculated.
Muscle Biopsy
Bilateral biopsies of the medial head of the gastrocnemius muscles were performed at rest in both legs of morphology and connective tissue, and acid phosphatase for necrosis. 21 The diameter, number, and percent cross-sectional area of each fiber type were calculated using standard morphometric techniques from cryostat sections stained for myosin ATPase (pH 9.4) activity. The optimal number of fields that needed to be sampled was determined by an iterative process that minimized the withinsubjects standard deviation of each measurement but without oversampling.22 To calculate fiber diameter and number, every eighth microscopic field (field size, 0.293 mm2) was photographed and projected to a final magnification of x364. The diameter of each fiber was determined as the maximum measure of the lesser fiber axis that would correct for any fibers cut at an oblique angle. The number of type I and II fibers were counted in the same fields and are expressed as a percent of the total number. The percent of angular fibers (indicating denervation) was also determined from these fields.
The cross-sectional area of each fiber type was estimated using the point-grid method. 
Statistical Analysis
Student's t test for paired data or a within-subjects ANOVA was used for within-subjects comparisons, and an unpaired t test was used for between-subjects comparisons. Linear regression was used for calculating correlations between variables. Categorical data were analyzed using the X 2or Fisher's exact probability tests. Values are given as mean±SD and considered significant when p<0.05 in a two-tailed test. In control subjects, the functional, histological, and biochemical data were similar between legs; therefore, the results were averaged from both legs.
Results

Patient Characteristics
Patients with PAD were well matched to the control subjects for age but had a reduced peak exercise performance as defined by treadmill walking time and peak oxygen consumption (Table 1) . Patients reported symptoms of intermittent claudication for 6±8 years with a range of 1-45 years. In all patients with PAD (unilateral and bilateral subjects), the most diseased leg had an abnormal ABI at rest that decreased further after exercise ( Table 1 ). The average resting and postexercise ABIs in the unilateral patient's nonsymptomatic legs were in the normal range as previously defined and significantly greater than in their diseased legs (Table  1) . However, postexercise ABIs in the nonsymptomatic legs were significantly lower than in control subjects, suggesting the possibility of mild arterial disease in the nonsymptomatic leg.
Muscle Strength and Endurance
In all 26 PAD patients, gastrocnemius muscle strength in their diseased legs was 43% less and anterior tibial strength was 31% less than the corresponding values in the control subjects (Table 2) . Gastrocnemius muscle endurance in the diseased legs was 38% less than that observed in the control subjects. In the subset of patients with unilateral disease, gastrocnemius strength ( Figure 1 , top panel) and endurance were less in the diseased than in the nonsymptomatic legs, but strength in the anterior tibial muscles was not different between legs ( Table 2) .
Estimates of Muscle Cross-sectional Area
The maximal calf cross-sectional area was estimated by measurements of circumference and by CT scans of the calf muscles. In patients with unilateral PAD, their diseased legs had 5% reduction (p<0.05 using a paired analysis) in cross-sectional area compared with their nonsymptomatic legs ( Table 2 ). In contrast, the calf cross-sectional area in diseased legs, measured by either method, was not different from control values due to the large standard deviation of the measurement in the PAD patients.
Muscle Histology
Histological analysis of the muscle samples was performed only in the unilateral PAD patients and in controls. Representative micrographs of gastrocnemius muscle are shown as follows: from a control subject using myosin ATPase stain (Figure 2A) , from the diseased leg of a unilateral PAD subject using myosin unilateral PAD subject stained with NADH-TR ( Figure  2C) . Qualitatively, the muscle samples from patients and controls showed no evidence of inflammation, fiber necrosis, or unusual accumulations of intercellular fat, connective tissue, or glycogen. However, all diseased legs of unilateral patients had histological evidence of denervation consisting of angular ( Figure 2C ), or target, fibers. In addition, fiber-type grouping, suggesting reinnervation, was seen in five of the 10 diseased legs ( Figure 2B ). Taken together, histological evidence of denervation or reinnervation was observed less often in the nonsymptomatic legs (40%, p<0.05) or in control legs (36%, p<0.05) than in the diseased legs (100%).
Fiber type distribution, diameter, and area were also determined in biopsies from the unilateral PAD patients and control subjects. Type I fiber diameter and the average number of type I fibers per field did not differ among diseased, nonsymptomatic, and control legs (Table 3) . Type II diameter and the average number of type II fibers per field were also similar for the diseased and control legs. However, type II fiber area in the diseased leg (measured independently of diameter or number) was 38% of the total fiber area, which was less than the type II area in the nonsymptomatic (49%) and control (48%) legs (Figure 1, treadmill. In the patients with unilateral disease, gastrocnemius muscle strength was correlated with total cross-sectional area of the calf (Figure 3, top panel) and type II fiber area (Figure 3, bottom panel) , but similar correlations were not observed in the nonsymptomatic legs. Finally, gastrocnemius strength in the diseased legs of all patients was correlated with peak walking time on the treadmill (r=0.41, p<0.05, y=0.18x+2.75).
Despite the large population variation in citrate synthase activity of all diseased legs in the PAD subjects, there was no correlation between citrate synthase activity and peak treadmill walking time (r= -0.23, p=0.26) or with gastrocnemius muscle strength or endurance in the diseased legs. Phosphofructokinase and lactate dehydrogenase activities were also not correlated with muscle strength or treadmill exercise performance. In contrast, citrate synthase activity in control legs was correlated with peak walking time (r=0.86, p<0.05, y=0.09x+ 13.87 weakness in the diseased legs, and the muscle weakness contributed to the impairment in exercise performance. As another control, results from the nonsymptomatic legs confirmed that the histological and functional changes in the diseased legs were not the result of deconditioning, aging, or environmental factors.
Previous studies have shown that PAD is associated with alterations in skeletal muscle histology. Necrotic and regenerating fibers as well as inflammation have been seen in the diseased legs of patients with unilateral PAD hospitalized for surgical evaluation30 and in patients with severe ischemic disease.5 In this study, ambulatory patients with less severe symptoms of claudication had no findings of fiber necrosis, inflammation, or accumulations of glycogen, fat, or connective tissue in their diseased legs, and the muscle fibers appeared normal. Thus, milder forms of the disease are not associated with generalized morphological changes in skeletal muscle. In contrast, signs of denervation (angular fibers) and reinnervation (grouped fibers) occur both in ambulatory patients with claudication7 and, to a greater degree, in patients with ischemic rest pain or gangrene.5,31 In this study, histological evidence of denervation was found in all diseased legs of PAD patients. Another study, using electrophysiological techniques, has confirmed that the muscle denervation in patients with unilateral claudication was limited to the distal motor axons, and the degree of denervation was correlated with the severity of the vascular disease. 32 Thus, skeletal muscle denervation in PAD may be due to ischemic damage of the distal motor nerves (Figure 3 ).
Muscle weakness has been reported in PAD patients, but the decrease in strength was only weakly correlated with walking tolerance.8 In our study, gastrocnemius strength correlated with peak treadmill walking time, but the low correlation coefficient suggests that other factors are more important to walking ability than muscle strength in patients with PAD.
In the unilateral patients, the nonischemic histological state of the individual's muscle was determined in their nonsymptomatic legs. Although type II fiber diameter in patients' nonsymptomatic legs was less than in the diseased or control legs, the average number of type II fibers in the nonsymptomatic leg was increased compared with the diseased leg (Table 3) marker enzyme not expected to change9-11,13) , there remained no differences between diseased and nonsymptomatic or control legs. Finally, given the variability in enzyme activities, additional patients with bilateral PAD were enrolled. The results confirm that PAD was not associated with either an increase or decrease in enzyme activities but that the population displays substantial heterogeneity. This heterogeneity is not unexpected in ambulatory PAD subjects given the multiple influences of vascular disease severity, denervation, and level of fitness on enzyme activities, as discussed above. Finally, regardless of any absolute changes in oxidative enzyme activities previously reported, the functional significance has not been well established. The lack of correlation between citrate synthase activity and muscle strength or exercise performance in the PAD subjects suggests that any adaptations in oxidative enzymes do not compensate for their muscle dysfunction or decreased exercise performance. In contrast, the expected correlation between citrate synthase activity and exercise performance was observed in the control group.
Thus, the chronic response of skeletal muscle in PAD is characterized by denervation and a decreased type II fiber area. These changes are associated with muscle atrophy and a loss of muscle strength that may contribute to the functional impairment in this population.
